1 | 934353-76-1 | ENMD-2076 | ENMD-2076 | C21H25N7
| 标准品;血管生成;小分子抑制剂;细胞生物学试剂;小分子抑制剂,天然产物 | |
2 | | 1-Butyl-2,6-bis(1H-benzotriazol-1-yl)piperidine | 1-Butyl-2,6-bis(1H-benzotriazol-1-yl)piperidine | C21H25N7
| | |
3 | 302944-81-6 | 1H-indole-3-carbaldehyde (2,6-dipyrrolidin-1-ylpyrimidin-4-yl)hydrazone | 1H-indole-3-carbaldehyde (2,6-dipyrrolidin-1-ylpyrimidin-4-yl)hydrazone | C21H25N7
| | |
4 | 726198-82-9 | 6-((4-PHENYLPIPERAZIN-1-YL)METHYL)-N2-M-TOLYL-1,3,5-TRIAZINE-2,4-DIAMINE | 6-((4-PHENYLPIPERAZIN-1-YL)METHYL)-N2-M-TOLYL-1,3,5-TRIAZINE-2,4-DIAMINE | C21H25N7
| | |
5 | 934353-77-2 | 6-(4-甲基-1-哌嗪基)-N-(5-甲基-1H-吡唑-3-基)-2-[(1Z)-2-苯基乙烯基]-4-嘧啶胺 | 6-(4-Methyl-1-piperazinyl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[(1Z)-2-phenylethenyl]-4-pyrimidinamine | C21H25N7
| | |
6 | 2757293-17-5 | 2-Pyrimidinamine, N-(1-methyl-1H-pyrazol-4-yl)-4-[8-(phenylmethyl)-3,8-diazabicyclo[3.2.1]oct-3-yl]- | 2-Pyrimidinamine, N-(1-methyl-1H-pyrazol-4-yl)-4-[8-(phenylmethyl)-3,8-diazabicyclo[3.2.1]oct-3-yl]- | C21H25N7
| | |